论文信息 - Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial - 字舞流文

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

R. Landewé | D. Heijde | A. Deodhar | L. Gensler | W. Abi-Saab | T. Hendrikx | W. Maksymowych | V. Tseluyko | X. Baraliakos | N. Mozaffarian | O. Nadashkevich | R. Besuyen | Ke Liu | Chantal Tasset | L. Meuleners | J. Greer | Joy M. Greer